Next generation sequencing Market Size, Share, Growth | Report 2025

Next generation sequencing Market Forecast to 2025 – COVID-19 Impact and Global Analysis – by Product (Platforms, Services, and Consumables); Technology (Genome Sequencing, Exome Sequencing, Resequencing & Targeted Sequencing, and Other); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other); and End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Others) 

Publication Month : Mar 2018

  • Report Code : TIPHE100000820
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 278
Inquire Before Buy

PRICING

$4550

$2730

The next generation sequencing market is projected to reach US$ 26,501.2 million by 2025 from US$ 4,274.9 million in 2016; it is expected to grow at a CAGR of 21.1% from 2016 to 2025.  

Next-generation sequencing (NGS), also known as high-throughput sequencing. NGS enables rapid sequencing of the base pairs in DNA or RNA samples. NGS is driving discovery and enabling the future of personalized medicine, genetic diseases, and clinical diagnostics. However, in this research study, the products of NGS have been classified into three broad segments as consumables, services and platforms.

The next generation sequencing market is segmented on the bases of products, technology, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.    

Lucrative Regions for Next generation sequencing Market

Lucrative Regions for Next generation sequencing Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Declining Price of Sequencing Drives Next generation sequencing Market Growth

In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduces to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.

Owing to factors such as advances in the field of genomics, development in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing.

Technological Advancements in Sequencing Contributes Significantly to Market Growth

Advancement in the field of molecular biology has equally enhanced the sequencing procedures. Many industry players have come up with innovative NGS technology in last few years. For instance, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION. Additionally, three advances NSG systems that dominate the market includes Roche GS FLX (454), Illumina HiSeq 2000 (Solexa) and AB SOLiD (Agencourt).

Further modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a “digital” alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR.

Advancement in genome sequencing has made the sequencing easy and accurate. These technological advancement are likely to grow the market in near future.

Products Insights              

Based on products, the next generation sequencing market is segmented into consumables, services, and platforms. In 2016, the consumables segment held the largest share of the market and is expected to grow at the highest CAGR during 2016–2025. The consumables are used in the numerous stages of the next generation sequencing procedures which include sample generation, storing the samples and its purification, preparation of the library and quantification, and PCR amplification. The consumables offered by various companies are widely accepted by the consumers and it provides accuracy and precision in the preparation of the next generation sequencing which is major factor for the growth of the segment in the next generation sequencing market.

Technology Insights

Based on technology, the next generation sequencing market is segmented into genome sequencing, exome sequencing, resequencing & targeted sequencing and other. The resequencing & targeted sequencing segment held the largest market share in 2016, and it is further expected to be the largest shareholder in the market by 2025. In targeted resequencing, a subset of genes or regions of the genome are isolated and sequenced. Targeted methods which use NGS allows the researchers in focusing on the time, expenses, and data analysis on specific areas of interest. The growing funding by various government bodies and usage of next generation sequencing in the resequecing and targeted sequencing which is bolstering the market growth of this segment.  

Application Insights

Based on application, the global next generation sequencing market is segmented into diagnostics, drug discovery, precision medicine and others. In 2016, the diagnostics segment held the largest share of the market. Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2016–2025. The use of next-generation sequencing (NGS) technology in the diagnostic genome care needs precision and accuracy. The NGS technologies use sequencing which are cost efficient to gain genomic information about the patients from the whole-genome sequencing to perform the clinical actions. The various advantages of NGS include testing many genes in one go and relatively short time and at lower costs. This enables maximum number of NGS diagnostic procedures in short span of time. The new technological advanced machines have led towards the prime growth rate of the diagnostics next generation sequencing market

End User Insights

Based on end user, the global next generation sequencing market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics and others. In 2016, the academic & research institutes segment held the largest share of the market and it is further expected to be the largest shareholder in the market by 2025. Many of the organizations have formed due to the partnerships between various organizations and universities for research in the transformation of scientific technologies to make the life-saving treatments for patients. The academic & research institutes are getting funds from the various organizations for the research and development sector for the betterment of NGS. The funding for the academic & research institutes have boosted the market share for the segment in the NGS market.

Next generation sequencing Market, by Product – 2016 and 2025

Next generation sequencing Market, by Product – 2016 and 2025
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Next generation sequencing Market: Strategic Insights

next-generation-sequencing-market
Market Size Value inUS$ 4,274.9 Million in 2016
Market Size Value byUS$ 26,501.2 Million by 2025
Growth rateCAGR of 21.1% from 2017-2025
Forecast Period2017-2025
Base Year2017
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches, and mergers and acquisitions are the highly adopted strategies by the players operating in the global next generation sequencing market. A few of the recent key product developments are listed below:

In January 2018, Illumina, Inc. launched iSeq 100 sequencing system, known to deliver exceptional data accuracy at low cost, which makes Illumina technology available to any lab.

In February 2018, Thermo Fisher Scientific launched the Applied Biosystems Axiom Microbiome Array for simultaneous detection of fungi, protozoa, bacteria, archea, and viruses in human samples. With the launch, orthogonal approach to interpretation of diverse microbiota has become possible.  

Next generation sequencing – Market Segmentation

By Products

  • Consumables
  • Services
  • Platforms

By Technology

  • Genome Sequencing   
  • Exome Sequencing
  • Resequencing & Targeted Sequencing
  • Other

By Application

  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • Other

By End User

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies,
  • Hospitals & Clinics
  • Others

By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)

    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East & Africa
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • ILLUMINA, INC.
  • Thermo Fisher Scientific
  • Qiagen N.V.
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product ; Service ; Application ; & End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

Frequently Asked Questions


What is NSG?

Next-generation sequencing (NGS), additionally called high-throughput sequencing. NGS permits fast sequencing of the base-pairs in deoxyribonucleic acid or ribonucleic acid samples.

What will be the CAGR of next generation sequencing market?

The Next generation sequencing in healthcare market is projected to reach US$ 26,501.2 million by 2025; it is expected to grow at a CAGR of 21.1%.

What is the prime factor which can drive market demand?

In recent years, the cases of cancer are increasing enormously and also the trend is anticipated to stay an equivalent within the forthcoming years. Modification in life-style has resulted in additional exposure to oncogenic factors. Cancer sequencing exploitation next-generation sequencing (NGS) strategies provides additional data and aids in medicine and treatment of cancer. Increase in cancer cases is main issue driving the demand for NSG market throughout forecast amount

Which segment is dominating the market?

The consumables section has the most important market share among the product section. Consumables section is poised to grow with a highest CAGR of 21.6% throughout the forecast period. The section is growing and thanks to the consumables offered by varied firm’s square measure wide accepted by the customers with smart accuracy and preciseness within the preparation of the NGS.

What is the COVID 19 impact on the NSG market?

The Next generation sequencing in healthcare market is expected to witness substantial growth post-pandemic.

The List of Companies

1. Illumina, Inc.2. Thermo Fisher Scientific, Inc.3. Qiagen N.V.4. Beijing Genomics Institute5. Perkinelmer, Inc.6. F. Hoffmann-La Roche AG7. Agilent Technologies8. Eurofins Scientific9. Oxford Nanopore Technologies, Ltd.10. Macrogen, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Next generation sequencing Market